AJMC March 2, 2025
Karen Winkfield, MD, PhD, addresses the importance of inclusive clinical trial participation and meeting patients where they are.
The ongoing call for research and studies to better reflect a real-world population has never been more important, with experts from across the medical community—from the psoriatic arthritis and prostate cancer spaces to patient navigation experts—sounding the alarm on enhancing diversity in clinical trials and for research to more accurately represent who will receive a treatment.
The current political climate has only served to heighten this awareness, with the FDA’s decision to remove draft guidance on clinical trial diversity from its website sparking controversy almost immediately, as well as diversity, equity, and inclusion (DEI) rollbacks happening at an increasingly fast pace since...
Today's Sponsors
Today's Sponsor